Prot #INCB 54329-101: Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054329 in Subjects With Advanced Malignancies

Project: Research project

Project Details

StatusFinished
Effective start/end date9/11/15 → 9/11/18

Funding

  • Covance Inc. (Prot #INCB 54329-101)
  • Incyte Corporation (Prot #INCB 54329-101)